The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

India’s pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 ...

India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the ...

Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its ...

The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...

The implementation of the revised Schedule M marks a critical step towards enhancing the quality and safety of pharmaceutical ...

With a 10% tariff making Chinese products costlier, US importers may turn to Indian companies as cost-effective alternatives.

The finest minds from the pharma firmament will also be sharing insights on the changing landscape and on the new imperatives ...

However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

India's pharmaceutical exports are projected to reach USD 65 billion by 2030, with a target of USD 350 billion by 2047, ...

China geopolitical tensions, China's Fosun Pharmaceutical is in discussions with three global private equity firms to sell ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.